Suchergebnisse
Suchergebnisse:
Arvid Carlsson (* 25. Januar 1923 in Uppsala; † 29. Juni 2018 [1] in Göteborg) war ein schwedischer Pharmakologe, der durch seine Arbeiten mit dem Neurotransmitter Dopamin bekannt wurde. Zusammen mit Eric Kandel und Paul Greengard erhielt er im Jahre 2000 den Nobelpreis für Physiologie oder Medizin „für ihre Entdeckungen zur ...
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000, together with Eric Kandel and Paul Greengard .
Arvid Carlsson The Nobel Prize in Physiology or Medicine 2000 . Born: 25 January 1923, Uppsala, Sweden . Died: 29 June 2018, Gothenburg, Sweden . Affiliation at the time of the award: Göteborg University, Gothenburg, Sweden . Prize motivation: “for their discoveries concerning signal transduction in the nervous system” Prize share: 1/3
26. Okt. 2018 · On 29 June 2018, neuropsychopharmacology and the American College of Neuropsychopharmacology (ACNP) lost one of its giants and true pioneers, Dr. Arvid Carlsson, MD, PhD, Swedish pharmacologist...
- Birte Glenthøj, H. Christian Fibiger
- 2019
25. Apr. 2024 · Arvid Carlsson, Swedish pharmacologist who, along with Paul Greengard and Eric Kandel, was awarded the 2000 Nobel Prize for Physiology or Medicine for his research establishing dopamine as an important neurotransmitter in the brain. Carlsson’s work led to a treatment for Parkinson disease.
- The Editors of Encyclopaedia Britannica
Arvid Carlsson was a Swedish pharmacologist who discovered dopamine as a neurotransmitter and its role in Parkinson's disease. He also contributed to the dopamine hypothesis of schizophrenia and the development of biological psychiatry and neurology in Scandinavia and beyond.
14. Okt. 2009 · Abstract. Translational medicine has recently experienced an upsurge in interest and funding, yet the idea is not new. More than half a century ago, the Swedish scientist Arvid Carlsson performed basic research on the neurotransmitter dopamine that was rapidly translated into the first clinical treatment for Parkinson ’s disease.
